Department of Pediatrics

Recent Publications view all (6)

Publication Co-Authors

Megan A. Cooper, M.D., Ph.D.

Anthony R. French, MD, PhD

Washington University has a long tradition of collaboration amongst colleagues.The faculty above have co-authored publications with Joshua B. Alinger

1. Throm AA, Alinger JB, Pingel JT, Daugherty AL, Pachman LM, French AR.. Dysregulated NK cell PLCγ2 signaling and activity in juvenile dermatomyositis. JCI Insight. 2018;15(3):22. PMCID:PMC6302943  PMID:30429375 
2. Mah AY, Rashidi A, Keppel MP, Saucier N, Moore EK, Alinger JB, Tripathy SK, Agarwal SK, Jeng EK, Wong HC, Miller JS, Fehniger TA, Mace EM, French AR, Cooper MA. Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control. JCI Insight. 2017;2(23). PMCID:PMC5752285  PMID:29212951 
3. Schwarz TM, Edwards MR, Diederichs A, Alinger JB, Leung DW, Amarasinghe GK, Basler CF. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability. J Virol. 2017;91(4). PMCID:PMC5286879  PMID:27974555 
4. Xu W, Edwards MR, Borek DM, Feagins AR, Mittal A, Alinger JB, Berry KN, Yen B, Hamilton J, Brett TJ, Pappu RV, Leung DW, Basler CF, Amarasinghe GK. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe. 2014;16(2):187-200. PMCID:PMC4188415  PMID:25121748 
5. Crane DD, Ireland R, Alinger JB, Small P, Bosio CM. Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via toll-like receptor 2 and peroxisome proliferator-activated receptor α. Clin Vaccine Immunol. 2013;20(10):1531-40. PMCID:PMC3807199  PMID:23925884 
6. Ireland R, Wang R, Alinger JB, Small P, Bosio CM. Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8. J Immunol. 2013;191(3):1276-86. PMCID:PMC3729262  PMID:23817430